Section Arrow
Quote
AMRX.NASDAQ
- Amneal Pharmaceuticals
Quotes are at least 15-min delayed:2025/02/23 04:09 EST
Last
 7.85
-0.02 (-0.25%)
Day High 
7.95 
Prev. Close
7.87 
1-M High
9.045 
Volume 
1.31M 
Bid
7.65
Ask
7.83
Day Low
7.735 
Open
7.92 
1-M Low
7.64 
Market Cap 
2.44B 
Currency USD 
P/E 89.5 
%Yield -- 
10-SMA 7.87 
20-SMA 8.17 
50-SMA 8.06 
52-W High 9.475 
52-W Low 5.01 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.86/0.96
Enterprise Value
4.96B
Balance Sheet
Book Value Per Share
-0.30
Cash Flow
Cash Flow Yield
0.14
Income Statement
Total Revenue
2.39B
Operating Revenue Per Share
7.46
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
UPCUniverse Pharmaceuticals Inc0.2003+0.0578+40.56%-- 
TLRYTilray Brands0.9452+0.0775+8.93%-- 
CGCCanopy Growth Corp1.615+0.005+0.31%-- 
TXMDTherapeuticsMD1.291+0.281+27.82%0.39PE
TEVATeva Pharmaceutical Industries Limited16.74-0.26-1.53%-- 
Quotes are at least 15-min delayed：2025/02/23 04:09 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targetingthe central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.